Mufg Securities Emea PLC Biogen Inc. Transaction History

Mufg Securities Emea PLC

$79.3 Billion
Q2 2025

A detailed history of Mufg Securities Emea PLC transactions in Biogen Inc. stock. As of the latest transaction made, Mufg Securities Emea PLC holds 431 shares of BIIB stock, worth $64,361. This represents 0.07% of its overall portfolio holdings.

Number of Shares

431

Holding current value

$64,361

% of portfolio

0.07%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 15, 2025	BUY	$113.38 - $135.49 $48,866 - $58,396	431 New	431 $54.1 Million
Q2 2022 Aug 15, 2022	SELL	$187.54 - $223.02 $139,717 - $166,149	-745 Closed	0 $0
Q1 2022 May 10, 2022	SELL	$193.77 - $244.14 $2.32 Million - $2.92 Million	-11,980 Reduced 94.15%	745 $157,000
Q4 2021 Feb 11, 2022	BUY	$223.92 - $287.77 $2.85 Million - $3.66 Million	12,725 New	12,725 $3.05 Million
Q2 2021 Jul 19, 2021	SELL	$259.0 - $414.71 $1.66 Million - $2.65 Million	-6,395 Closed	0 $0
Q1 2021 May 11, 2021	SELL	$242.95 - $284.63 $157,917 - $185,009	-650 Reduced 9.23%	6,395 $1.79 Million
Q4 2020 Feb 11, 2021	SELL	$236.26 - $355.63 $16.3 Million - $24.5 Million	-68,984 Reduced 90.73%	7,045 $1.73 Million
Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $289,923 - $334,752	1,095 Added 1.46%	76,029 $21.6 Million
Q2 2020 Aug 13, 2020	SELL	$258.66 - $342.55 $25.9 Million - $34.3 Million	-100,066 Reduced 57.18%	74,934 $20 Million
Q1 2020 May 12, 2020	BUY	$268.85 - $341.04 $16.1 Million - $20.5 Million	60,000 Added 52.17%	175,000 $55.4 Million
Q4 2019 Feb 11, 2020	BUY	$220.06 - $304.07 $7.99 Million - $11 Million	36,300 Added 46.12%	115,000 $34.1 Million
Q3 2019 Nov 12, 2019	BUY	$217.44 - $243.88 $804,528 - $902,356	3,700 Added 4.93%	78,700 $18.3 Million
Q2 2019 Aug 13, 2019	SELL	$219.29 - $241.72 $25.3 Million - $27.9 Million	-115,600 Reduced 60.65%	75,000 $17.5 Million
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $21,671 - $33,896	100 Added 0.05%	190,600 $45.1 Million
Q4 2018 Feb 14, 2019	BUY	$278.5 - $352.75 $25.4 Million - $32.1 Million	91,039 Added 91.53%	190,500 $57.3 Million
Q3 2018 Nov 13, 2018	BUY	$293.51 - $383.83 $29.1 Million - $38.1 Million	99,225 Added 42044.49%	99,461 $35.1 Million
Q2 2018 Aug 01, 2018	SELL	$257.52 - $306.91 $5.09 Million - $6.07 Million	-19,764 Reduced 98.82%	236 $68,000
Q4 2017 Feb 06, 2018	BUY	$307.64 - $344.58 $6.15 Million - $6.89 Million	20,000	20,000 $6.37 Million

Others Institutions Holding BIIB

# of Institutions

1,049

Shares Held

131M

Call Options Held

2.84M

Put Options Held

2.54M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.5B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Mufg Securities Emea PLC, based on Form 13F filings with the SEC.

News

Stay updated on Mufg Securities Emea PLC with notifications on news.

Account

Mufg Securities Emea PLC Biogen Inc. Transaction History